Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | POLA1 | P09884 | 1/20 | 0.47 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.43 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | RNASE1 | P07998 | 1/20 | 0.35 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.35 |
| ▸ | PNP | P00491 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21538044 | 0.90 | KDM4E (0.81) | KDM4EPOLA1TAS1R3TAS1R1ALDH1A1 | |
| SCHEMBL19035574 | 0.89 | KDM4E (0.79) | KDM4EPOLA1TAS1R3TAS1R1HPGD | |
| SCHEMBL23225351 | 0.87 | KDM4E (0.77) | KDM4EPOLA1TAS1R3TAS1R1ALDH1A1 | |
| SCHEMBL19662708 | 0.85 | KDM4E (0.75) | KDM4EPOLA1TAS1R3TAS1R1ALDH1A1 | |
| SCHEMBL21538041 | 0.85 | KDM4E (0.75) | KDM4EPOLA1TAS1R3TAS1R1ALDH1A1 | |
| SCHEMBL19662704 | 0.85 | KDM4E (0.75) | KDM4EPOLA1TAS1R3TAS1R1ALDH1A1 | |
| SCHEMBL22315215 | 0.85 | KDM4E (0.74) | KDM4EPOLA1TAS1R3TAS1R1ALDH1A1 | |
| SCHEMBL9703289 | 0.85 | KDM4E (0.74) | KDM4EPOLA1TAS1R3TAS1R1ALDH1A1 | |
| SCHEMBL18166264 | 0.85 | KDM4E (0.74) | KDM4EPOLA1TAS1R3TAS1R1ALDH1A1 | |
| SCHEMBL16568124 | 0.84 | KDM4E (0.73) | KDM4EPOLA1TAS1R3TAS1R1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260043172-A1 | METHODS AND SYSTEMS FOR GENERATING NUCLEIC ACID DIVERSITY IN CRISPR-ASSOCIATED GENES | PASTEUR INSTITUT (FR) | 2026-02-12 | — | — | US | disclosed |
| EP-4522754-A1 | SYNTHETIC SELF-AMPLIFYING MRNA MOLECULES WITH SECRETION ANTIGEN AND IMMUNOMODULATOR | Sunvax MRNA Therapeutics Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| EP-4517451-A1 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND INFORMATION PROCESSING PROGRAM | Yokogawa Electric Corporation (JP) | 2025-03-05 | — | — | EP | disclosed |
| US-20250068437-A1 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND COMPUTER-READABLE RECORDING MEDIUM | YOKOGAWA ELECTRIC CORPORATION (JP) | 2025-02-27 | — | — | US | disclosed |
| CN-119512622-A | Information processing apparatus, information processing method, and computer-readable recording medium | 横河电机株式会社 | 2025-02-25 | — | — | CN | disclosed |
| WO-2025010420-A2 | COMPOSITIONS AND METHODS FOR DELIVERING MOLECULES | SunVax mRNA Therapeutics Inc. (US) | 2025-01-09 | — | — | WO | disclosed |
| US-20240182886-A1 | METHODS AND SYSTEMS FOR GENERATING NUCLEIC ACID DIVERSITY | INSTITUT PASTEUR (FR) | 2024-06-06 | — | — | US | disclosed |
| WO-2023220693-A1 | SYNTHETIC SELF-AMPLIFYING MRNA MOLECULES WITH SECRETION ANTIGEN AND IMMUNOMODULATOR | SunVax mRNA Therapeutics Inc. (US) | 2023-11-16 | — | — | WO | disclosed |
| EP-3412765-B1 | METHOD FOR PRODUCING MUTANT FILAMENTOUS FUNGI | KAO CORP (JP) | 2023-01-18 | — | — | EP | disclosed |
| CN-115239477-A | Interest calculation method and device | 中国银行股份有限公司 | 2022-10-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260043172-A1 | METHODS AND SYSTEMS FOR GENERATING NUCLEIC ACID DIVERSITY IN CRISPR-ASSOCIATED GENES | MUS81, DHX9, POLR1E | KDM4E 1595/4885POLA1 108/4885TAS1R3 3023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.